Effect of priming with granulocyte–macrophage colony-stimulating factor in younger adults with newly diagnosed acute myeloid leukemia: a trial by the Acute Leukemia French Association (ALFA) Group
Xavier Thomas(Hôpital Lyon Sud), Hervé Dombret(University of London Institute in Paris), Pierre Fenaux(Saint Louis University Hospital), Stéphane de Botton(Université Paris-Saclay), Claude Preudhomme(Centre Hospitalier Universitaire de Lille), Mohamed Elhamri(Hôpital Edouard Herriot), Bernadette Corront(Centre Hospitalier Annecy Genevois), Catherine Cordonnier(Université Paris-Est Créteil), Thierry de Revel(Hôpital d'instruction des Armées Percy), Cécile Pautas(Centre Hospitalier Universitaire Henri-Mondor), Claude Gardin(Sorbonne Université), Emmanuel Raffoux(Inserm), Bruno Quesnel(Université de Lille), Mauricette Michallet(Université Claude Bernard Lyon 1), P Arnaud(Institut Gustave Roussy), Sylvie Castaigné(Hôpital André Mignot), JH Bourhis(Institut Gustave Roussy), Oumédaly Reman(Centre Hospitalier Universitaire de Caen), Q.H. Le(The Lymphoma Academic Research Organisation), Christine Terré(Hôpital André Mignot)
Cited by 76
Related Papers
Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel
|Blood|2016|5.9k
Diagnosis and management of AML in adults: 2022 recommendations from an international expert panel on behalf of the ELN
|Blood|2022|3.1k